脂质丰富与非丰富斑块支架置入后2年结局
本研究为前瞻性多中心注册研究,在1999例冠脉造影患者中行近红外光谱(NIRS)检测,其中1621例接受PCI。2年随访主要不良心脏事件(MACE)发生率为18.0%,在校正临床和手术因素后,支架置入处maxLCBI4mm与罪犯病变相关MACE无显著关联(HR 1.06,95%CI 0.96-1.17,P=0.28)。
要点
- NIRS定义的脂质丰富斑块支架置入未增加围术期或晚期不良事件。
- 2年MACE发生率18.0%,罪犯病变相关8.3%,非罪犯病变相关10.7%。
- maxLCBI4mm每增加100,罪犯病变相关MACE风险无显著升高。
核心结论
- 在现代药物洗脱支架时代,NIRS定义的脂质丰富斑块支架置入与围术期及晚期不良结局增加无关。
研究设计与样本
- 前瞻性多中心注册研究(COLOR注册),共纳入1999例接受冠脉造影患者,其中1621例接受PCI。
主要发现
- 2年随访MACE发生率为18.0%,其中罪犯病变相关8.3%,非罪犯病变相关10.7%,不确定3.1%。
- NIRS成像并发症发生于9例(0.45%),导致1例围术期心肌梗死和1例紧急冠脉搭桥。
- 在校正临床和手术因素后,maxLCBI4mm每增加100与罪犯病变相关MACE无显著关联(HR 1.06,95%CI 0.96-1.17,P=0.28)。
关键数值与推荐
- 脂质核心负荷指数(LCBI)计算为感兴趣区内脂质丰富斑块概率>0.6的像素比例。
- maxLCBI4mm定义为任意4mm长节段内的最大LCBI。
- MACE包括心源性死亡、心肌梗死、明确或可能的支架血栓、或因进展性心绞痛或不稳定心绞痛计划外血运重建或再住院。
临床怎么用
- 对于NIRS检测到的脂质丰富斑块,使用现代药物洗脱支架置入未显示增加不良事件风险。
- NIRS成像并发症发生率低,但需注意围术期心肌梗死和紧急搭桥风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autopsy studies suggest that implanting stents in lipid-rich plaque (LRP) may be associated with adverse outcomes. OBJECTIVES: The purpose of this study was to evaluate the association between LRP detected by near-infrared spectroscopy (NIRS) and clinical outcomes in patients with coronary artery disease treated with contemporary drug-eluting stents. METHODS: In this prospective, multicenter registry, NIRS was performed in patients undergoing coronary angiography and possible percutaneous coronary intervention (PCI). Lipid core burden index (LCBI) was calculated as the fraction of pixels with the probability of LRP >0.6 within a region of interest. MaxLCBI4mm was defined as the maximum LCBI within any 4-mm-long segment. Major adverse cardiac events (MACE) included cardiac death, myocardial infarction, definite or probable stent thrombosis, or unplanned revascularization or rehospitalization for progressive angina or unstable angina. Events were subcategorized as culprit (treated) lesion-related, nonculprit (untreated) lesion-related, or indeterminate. RESULTS: Among 1,999 patients who were enrolled in the COLOR (Chemometric Observations of Lipid Core Plaques of Interest in Native Coronary Arteries Registry), PCI was performed in 1,621 patients and MACE occurred in 18.0% of patients, of which 8.3% were culprit lesion-related, 10.7% were nonculprit lesion-related, and 3.1% were indeterminate during 2-year follow-up. Complications from NIRS imaging occurred in 9 patients (0.45%), which resulted in 1 peri-procedural myocardial infarction and 1 emergent coronary bypass. Pre-PCI NIRS imaging was obtained in 1,189 patients, and the 2-year rate of culprit lesion-related MACE was not significantly associated with maxLCBI4mm (hazard ratio of maxLCBI4mm per 100: 1.06; 95% confidence interval: 0.96 to 1.17; p = 0.28) after adjusting clinical and procedural factors. CONCLUSIONS: Following PCI with contemporary drug-eluting stents, stent implantation in NIRS-defined LRPs was not associated with increased periprocedural or late adverse outcomes compared with those without significant lipid.
引用
- Yamamoto MH, Maehara A, Stone GW, et al. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques. J Am Coll Cardiol. 2020. PMID: 32216905. doi:10.1016/j.jacc.2020.01.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。